Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients

Area of Science:

• Gastroenterology
• Hepatology
• Pharmacology

Background:

• Gall stones (cholelithiasis) are a common condition.
• Radiolucent gall stones are amenable to non-surgical dissolution therapies.
• Cholelitholytic bile acids offer a medical treatment option for gall stone disease.

Purpose of the Study:

• To evaluate the efficacy of cholelitholytic bile acids in dissolving radiolucent gall stones.
• To determine factors influencing treatment success, such as stone size.
• To assess the impact of therapy on patient symptoms and recurrence.

Main Methods:

• A cohort of 24 patients with radiolucent gall stones received cholelitholytic bile acid therapy.
• Treatment outcomes were assessed based on gall stone dissolution.
• Patient symptoms, stone size, and recurrence rates were monitored.

Main Results:

• Complete gall stone dissolution was achieved in 8 patients (33%) and partial dissolution in 3 patients (13%).
• Therapy was unsuccessful for gall stones larger than 15 mm.
• Complete dissolution was achieved in only 47% of patients with stones ≤5 mm.
• No improvement or new onset of biliary pain occurred in asymptomatic patients.
• Three of six patients with prior biliary pain required surgery due to recurrence during therapy.

Conclusions:

• Cholelitholytic bile acid therapy shows limited efficacy for gall stone dissolution, particularly for larger stones.
• The treatment may not be effective in preventing biliary pain or recurrence in susceptible patients.
• Further research is needed to optimize medical management of gall stone disease.